Navigation Links
Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
Date:10/5/2010

es of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Further, the scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. FDA for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

CONTACT: Amgen, Thousand OaksAshleigh Koss: +1 (805) 313-6151 (Vectibix, Neulasta, Aranesp)Christine Regan: +1 (805) 447-5476 (denosumab)Leanne Madison: +1 (805) 447-1201 (Pipeline)Arvind Sood: +1 (805) 447-1060 (Investors)CONTACT: Amgen, ZugSabeena Ahmad: +41 41 3692 530 (denosumab)Carrie Deverell: +41 41 3690 308 (Vectibix, Pipeline)Toby Viering: +41 41 3692 519 (Aranesp, Neulasta)CONTACT: Amgen, CanadaSabrina Paiva: +1 (905) 285-3145(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 25, 2014  Unilife Corporation (NASDAQ: ... injectable drug delivery systems, today announced that its Chairman ... present at the Piper Jaffray 26th Annual Healthcare Conference ... EST on Tuesday, December 2, 2014. ... as a "live" listen only Webcast. To listen, please ...
(Date:11/26/2014)... Fla. , Nov. 25, 2014  Breckenridge ... into a multi-product ANDA agreement with Pii (Pharmaceutics ... ) under which Breckenridge and Pii expect to ... terms of the agreement, Pii will develop, manufacture ... and distribute the products under its own label.  ...
(Date:11/26/2014)... Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the ... conferences.  , 31 st NASDAQ Investor Program ... 2014 at 6:45 a.m. EST / 11:45 a.m. GMT. Iain ... provide an overview of the company and a business and financial ... in New York, NY on Tuesday, December ...
Breaking Medicine Technology:Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2
... of Victor, NY , announced today that the Company has ... the Qualifying Therapeutic Discovery Project (QTDP), which was created by ... Act of 2010. In July, PharmaNova applied for project grants ... nanoparticulate products. NovaSperse(SM) is a unique ...
... Nov. 8, 2010 Parascript, LLC, the image analysis ... was awarded a cash grant of $244,479.25 under the ... therapeutic discovery project program targets projects that show significant ... reduce the long-term growth of health care costs or ...
Cached Medicine Technology:NovaSperse(SM) Nanoparticle Innovator, PharmaNova, Inc., Awarded Four Government Grants Toward Development of New Therapeutic Products Under Congressional Qualifying Therapeutic Discovery Project Initiative 2Parascript Awarded $244,479.25 Affordable Care Act Grant From the U.S. Government 2
(Date:11/27/2014)... Burnsville MN (PRWEB) November 27, 2014 ... manufacturer of office ergonomics equipment , has announced ... partnership with Commercial Office Environments. The partnership will ... for office furnishings location. , In addition to ... the new dealer partnership promotes HealthPostures' products with ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. ... laughter as we enjoy the ugly sweater contest." Last ... scratch. " It was a sight to see. She ... enough, the Christmas balls were faces of the staff with ... participating this year, it's simple to get in on the ...
(Date:11/27/2014)... Delhi, India (PRWEB) November 27, 2014 Ethane ... has announced it will provide a 10% Christmas discount on ... month of December. The discount offer will begin on 1 ... 2014. , About this offer, a PPC professional working ... for all, especially for small businesses, as this big discount ...
(Date:11/27/2014)... Francisco, California (PRWEB) November 27, 2014 ... his search for vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum ... leading rock bands played at the University of Alabama. ... 1969. According to Hawley, “It started with Gary Weinberger ... and working at University Programs Council. The council was ...
(Date:11/26/2014)... 27, 2014 Recently, DressVe , ... occasion dresses, has unveiled its 2014 Cyber Monday Sales. ... new dresses, up to 90 percent off. The special ... 3. Free delivery is provided for orders above $69. ... dresses, shoes, handbags and other fashion accessories. The mission ...
Breaking Medicine News(10 mins):Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3Health News:Ethane Web Technologies Announces 10% Christmas Discount on PPC Service 2Health News:Serious Buyer Announces His Search For Vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum Concert Posters 2Health News:DressVe.com: Best 2014 Special Monday Sales Online 2
... super bug hounding them relentlessly. While patients battling diseases ... quite ‘sick’ with the alien invasion. Of particular virulence ... difficile, which networks with gusto among the NHS hospitals. ... annually is also known for its caprice and unpredictability. ...
... increasingly used to improve patient care. In a recent report the ... babies in US alone who succumb to sudden infant death syndrome ... the University of Texas has come up with a new solution ... ,Hung Cao, along with his friends developed a device that can ...
... method of blood test to diagnose Parkinson disease. This test ... the symptoms arrive. The test is done by a team ... University specialists. ,They have also created a genetic ... can screen many types of PD and monitor treatment for ...
... AVONEX(R) (Interferon beta-1a) Nurse Services program which is designed to ... continue treatment with AVONEX, the most prescribed treatment for relapsing ... with MS and as a nurse I can attest first-hand ... patients and their healthcare providers in both the treatment and ...
... nomads - the force-feeding of their girls. For to be ... ,Mothers cross sticks around the ankles and squeeze the ends ... ,That is one of forcing daughters to swallow ... end until they developed wings of fat hanging from their ...
... a simple information pamphlet to interested drinkers in the ... It is found to be a promising// public ... associated with heavy drinking, shows a new study. ... use have long been recognized as a potentially useful ...
Cached Medicine News:Health News:RFID Use can Avoid Sudden Infant Death Syndrome 2Health News:New Blood Test to Diagnose Parkinson Disease 2Health News:Multiple Sclerosis Patients to Benefit With AVONEX(R) Nurse Services Program 2Health News:Force-feeding a Scourge Among Mauritanian Nomads 2Health News:Force-feeding a Scourge Among Mauritanian Nomads 3Health News:Mailing Pamphlets can Reduce Alcohol Consumption 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: